Upload
claudia-morton
View
26
Download
1
Embed Size (px)
DESCRIPTION
International Critical Care Nutrition Survey 2009: Defining Gaps in Practice. Naomi E Cahill, RD MSc Project Leader Queen’s University/Clinical Evaluation Research Unit Kingston, Ontario, Canada. Acknowledgments. Participants of the International Nutrition Survey 2009 - PowerPoint PPT Presentation
Citation preview
International Critical Care Nutrition Survey 2009:
Defining Gaps in Practice
Naomi E Cahill, RD MScProject Leader
Queen’s University/Clinical Evaluation Research Unit
Kingston, Ontario, Canada
Acknowledgments
• Participants of the International Nutrition Survey 2009
• Dr Daren Heyland and the Research Team at the Clinical Evaluation Research Unit– Lauren Murch, Project Assistant– Rupinder Dhaliwal, Project Leader– Andrew Day, Biostatistician– Miao Wang, Data Analyst– Fernando Ferrer, IT Support
Benchmarking
Individual ICUs compared to:
•Canadian Clinical Practice Guidelines
•All ICUs
•ICUs from same geographic region
Objectives of International Survey
Quality Improvement• To observe current nutrition practice in the adult critical
care setting (overall and subgroups)• Define gaps between best practice and current practice • To identify opportunities for improvement
Generate New Knowledge• To identify factors associated with optimal provision of
nutrition • To determine what nutrition practices are associated with
best clinical outcomes
History of International Surveys
• 3 previous surveys in Canada– 2001, 2003, 2004– N > 50
• Extended to other countries in 2007 and 2008– 167 ICUs each year– >18 countries
– 65 ICUs from 10 countries participated in both years.
• Repeated in September 2009– Focus on North America
Methods
Eligibility Criteria• ICU Site
– >=8 beds– Availability of individual with knowledge of
clinical nutrition to collect data
• Patient– Adult >18 years– Mechanically ventilated within 48 hours– In ICU > 72 hours
Methods
• Start date: 16th September 2009
• Aim 20 consecutive patients– Min 8 pts
• Data included:– Hospital and ICU demographics– Patient baseline information (e.g. age, admission diagnosis,
APACHE II)– Baseline Nutrition Assessment– 12 days Daily Nutrition data (e.g. type of NS, amount NS
received)– 60 day hospital outcomes (e.g. mortality, length of stay)
Canada: 32
USA: 63
Australia & New Zealand: 22
Europe: 14
Latin America: 10
Asia: 16
Mexico: 2 Brazil:1Colombia:5Peru:1Venezuela:1
Italy: 2UK: 7
Ireland: 2Norway: 1
Switzerland: 1Czech Republic: 1
China: 1Taiwan: 1India: 10Iran : 1
Japan: 1Singapore: 2
Who participated in 2009? : 157 ICUs
ICU CharacteristicsCharacteristics Total (n=157)
Hospital Type
Teaching 116 (73.9%)
Non-teaching 41 (26.1%)
Size of Hospital (beds)
Mean (Range) 503 (50, 1500)
ICU Structure
Open 49 (31.2%)
Closed 104 (66.2%)
Other 4 (2.5%)
Size of ICU (beds)
Mean (Range) 19 (6, 64)
Designated Medical Director 149 (94.9%)
Presence of Dietitian(s) 145 (92.4%)
FTE Dietitians (per 10 beds)
Mean (Range) 0.4 (0.0, 1.7)
Patient CharacteristicsCharacteristics Total n=3032
Age (years)
Median [Q1,Q3] 61 [48, 73]
Sex
Female 1217 (40.1%)
Male 1815 (59.9%)
Admission Category
Medical 1954 (64.4%)
Surgical: Elective 366 (12.1%)
Surgical: Emergency 712 (23.5%)
BMI (kg|m2)
Median [Q1, Q3] 26.0 [22.8, 30.8]
Apache II Score
Median [Q1, Q3] 22 [17, 28]
Presence of ARDS
Yes 413 (13.6%)
Use of EN Only
n=17,574 patients days
73.6%
66.7%
93.9%
9.8%0
10
20
30
40
50
60
70
80
90
100
Canada Australia and New Zealand
USA Europe Latin America Asia Total
% IC
U d
ays
Use of PN Only
n=2,295 patients days
6.6% 8.7%
38.6%
0.6%0
5
10
15
20
25
30
35
40
45
50
Canada Australia and New Zealand
USA Europe Latin America Asia Total
% IC
U d
ays
Use of EN + PN
n=1,158 patients days
2.7%4.4%
72.2%
0.3%0
10
20
30
40
50
60
70
80
Canada Australia and New Zealand
USA Europe Latin America Asia Total
% IC
U d
ays
No EN, PN or Oral intake received
n=5,320 patients days
20.2%
61.7
4.30
10
20
30
40
50
60
70
Canada Australia and New Zealand
USA Europe Latin America Asia Total
% IC
U d
ays
17.2%
We recommend early enteral nutrition (within 24-48 hrs
following admission) in critically ill patients
Timing of Initiation of EN
41hrs
144hrs
9hrs0
24
48
72
96
120
144
168
Canada Australia and New Zealand
USA Europe Latin America Asia Total
Tim
e to
Init
iati
on
of
EN
(h
ou
rs)
35 hrs
An evidence based feeding protocol should be considered
as a strategy to optimize delivery of enteral nutrition
Feeding Protocol
Characteristics Total n=157
Feeding Protocol
Yes 129 (82.2%)
Gastric Residual VolumeThreshold
Mean (range) 240 (50, 500)
Algorithms included in Protocol
Motility agents 90 (72.6%)
Small bowel feeding 69 (55.6%)
Withholding for procedures 69 (55.6%)
HOB Elevation 117 (94.4%)
Other 19 (15.3%)
In critically ill patients who experience feed intolerance (high gastric residual volumes, emesis)
the use of a motility agent is recommended
Strategies to Optimize EN Delivery:Motility Agents
86%
66%
100.0
0.00
10
20
30
40
50
60
70
80
90
100
Canada Australia and New Zealand
USA Europe Latin America Asia Total
% p
atie
nts
with
HG
RV
In units were achieving routine small bowel access is not
feasible small bowel feeding should be considered for patients who repeatedly demonstrate high gastric residual volumes and are
not tolerating EN
Location of Feeding Tube
61%20%
11%
2%4% 2% 0% Gastric confirmed
Gastric presumed
Post-pyloric duodenalconfirmed
Post-pyloric duodenalpresumed
Post-pyloric jejunalconfirmed
Post-pyloric jejunalpresumed
No tube in place
Small Bowel Feeding
12%
100.0
0.00
10
20
30
40
50
60
70
80
90
100
CanadaAustralia and New ZealandUSA Europe Latin America Asia Total
% p
atie
nts
with
HG
RV
15%
Composition of EN and Pharmaconutrient Supplementation recommendationsArginine-supplemented formulas Recommend NOT be used
Glutamine supplementation
Enteral should be considered in burn and trauma
Parenteral strongly recommended in PN pts
Fish oil enriched formula Recommended in ARDS
Combined vitamins and trace elements
Should be considered
Polymeric Recommend
Use of EN Formula and Pharmaconutrients
Arginine-supplemented formulas 8.2%(0.0%-94.7%)
Glutamine supplementation (All) 5.9%(0.0%-95%)
Fish oil enriched formula (ARDS) 18.9% (0.0%-100%)
Selenium Supplementation (All) 3.1% (0.0%-100%)
Polymeric 85.9% (0.0%-100.%)
Blood Glucose >10 mmol/l
13
0
5
10
15
20
25
30
35
40
Canada Australia and New Zealand
USA Europe Latin America Asia Total
% p
atie
nt-
da
ys
13
Overall Performance
Adequacy of Nutrition Support =
Calories received from EN + appropriate PN+Propofol Calories prescribed
Overall Performance: Kcals
0
20
40
60
80
100
120
140
1 2 3 4 5 6 7 8 9 10 11 12
ICU Day
% r
ec
eiv
ed
/pre
sc
rib
ed
Mean of All Sites Best Performing Site Worst Performing Site
Overall Performance: Kcals
59 61
49
61
5155 55
0
10
20
30
40
50
60
70
80
90
100
Canada Australia and New Zealand
USA Europe Latin America Asia Total
% re
ceiv
e/p
resc
ribed
Where can we do better?
• Inadequate EN delivery– timing of initiation of EN– feeding protocols– small bowel feeding
• Optimize Pharmaconutrition– use of glutamine, antioxidants, omega-3 FFA.
• Tighten glycemic control
Nutritional Adequacy Over Time
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6 7 8 9 10 11 12
ICU Day
% r
ec
eiv
ed
/pre
sc
rib
ed
Year 2007 Year 2008 Year 2009